GlassScriptPhysician profile
Meher S Khan
NPI 1871555458
$1,034.10
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Allergy & Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $126 · 2021: $281 · 2024: $37.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $37.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $37.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $268.41 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $242.40 | 2019-2021 | |
| Genzyme Corporation | $168.56 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $123.17 | 2019 | |
| Csl Behring | $77.79 | 2019 | |
| Glaxosmithkline, LLC. | $41.98 | 2019 | |
| Impulse Dynamics (USA) INC. | $37.75 | 2024 | Optimizer |
| Shire North American Group INC | $27.59 | 2019 | |
| Pharming Healthcare, INC. | $16.62 | 2019 | |
| Greer Laboratories, INC. | $15.35 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meher Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.